U.S. News & World Report: Ovarian cancer causes, diagnosis and treatments
The University of Cincinnati's Amanda Jackson, MD, spoke with U.S. News & World Report about ovarian cancer risk factors and prevention.
“In most cases, the cause of ovarian cancer is unknown,” Jackson, University of Cincinnati Cancer Center physician-researcher and associate professor, division chief and vice chair in the UC College of Medicine’s Department of Obstetrics & Gynecology.
Jackson said the most common risk factor of ovarian cancer is increasing age, with additional risk factors including asbestos exposure, using fertility treatments and smoking and alcohol use.
“Since there is no screening test for ovarian cancer, patients are encouraged to speak to their doctor if they have any signs of ovarian cancer such as bloating, early fullness after eating, new constipation or nausea or unintentional weight loss,” Jackson said.
Read the U.S. News & World Report article.
Featured photo at top: ovarian cancer tumor in animal model. Photo/National Cancer Institute.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.